Aimei Investment Ltd bought $3.3M of AFJK
owner at Aimei Health Technology Co., Ltd.. 332,000 shares at an average of $10.00, traded Dec 1, 2023, filed Dec 5, 2023.
Score components
- +12Role10% owner
- +25Trade size$3.3M at market
- +6Relative to holdingsHoldings up 21%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-23-043708, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 1, 2023 | POpen-market purchase Ordinary Shares | +332,000 | $10.00 | $3.3M | 1,905,000 | Dec 5, 2023 |
| Dec 1, 2023 | POpen-market purchase Rightsderivative | +332,000 | - | - | 332,000 | Dec 5, 2023 |
Related signals
Other insiders at Aimei Health Technology Co., Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 42Moderate | AFJKsell Aimei Health Technology Co., Ltd. | Mizuho Securities USA LLC owner | $1.6M 150,000 shares | -21% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.